CD25 Antikörper (FITC)
Kurzübersicht für CD25 Antikörper (FITC) (ABIN641704)
Target
Alle CD25 (IL2RA) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Mouse Anti-Bovine CD25 [+FITC]
-
Produktmerkmale
- Adhesion Molecule/Cell Surface
-
-
anti-Interleukin 2 Receptor, alpha (IL2RA) (AA 201-268) antibody
IL2RA Reaktivität: Human, Maus FACS, WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 2 Receptor, alpha (IL2RA) (AA 34-139) antibodyIL2RA Reaktivität: Human, Maus, Ratte, Affe WB, IHC, ELISA, ICC Wirt: Maus Monoclonal 1B5D12 unconjugated
anti-Interleukin 2 Receptor, alpha (IL2RA) (AA 22-213) antibodyIL2RA Reaktivität: Human WB, ELISA, ICC, IHC (fro), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 2 Receptor, alpha (IL2RA) (AA 34-139) antibodyIL2RA Reaktivität: Human, Maus, Ratte, Affe WB, IHC, ELISA, IF/ICC Wirt: Maus Monoclonal unconjugated
anti-Interleukin 2 Receptor, alpha (IL2RA) antibodyIL2RA Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-181 unconjugated
anti-Interleukin 2 Receptor, alpha (IL2RA) (AA 22-245) antibodyIL2RA Reaktivität: Schwein WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 2 Receptor, alpha (IL2RA) antibody (PerCP)IL2RA Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-181 PerCP
anti-Interleukin 2 Receptor, alpha (IL2RA) antibodyIL2RA Reaktivität: Maus, Ratte WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 2 Receptor, alpha (IL2RA) (AA 42-183) antibodyIL2RA Reaktivität: Human IHC, StM Wirt: Maus Monoclonal IL2RA-2395 unconjugated
anti-Interleukin 2 Receptor, alpha (IL2RA) (AA 22-235) antibodyIL2RA Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Flow Cytometry
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- CD25 (IL2RA) (Interleukin 2 Receptor, alpha (IL2RA))
-
Andere Bezeichnung
- CD25
-
Pathways
- JAK-STAT Signalweg, Growth Factor Binding, Activated T Cell Proliferation
Target
-
